MedTrace Logo

Throat and Other HPV-Related Cancers in Men: Identifying Them Early

NCT02897427 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2026-01-26

No results posted yet for this study

Summary

This trial studies the screening of human papillomavirus (HPV)-related oropharyngeal and anogenital cancers. Learning the relationship between HPV and cancer risk in men who test positive for HPV antibodies or circulating HPV DNA may help doctors to develop early methods of screening for certain types of cancer, and screening for HPV may help doctors to learn which patients may be at a higher risk for developing certain types of cancer.

Conditions

  • Human Papillomavirus Infection

Interventions

OTHER

Biomarker Analysis

Complete HPV testing

PROCEDURE

Biospecimen Collection

Undergo collection of blood and oral gargle samples

PROCEDURE

Ultrasonography

Undergo transcervical ultrasonography

Sponsors & Collaborators

  • University of Texas Southwestern Medical Center

    collaborator OTHER

  • Cancer Prevention Research Institute of Texas

    collaborator OTHER

  • Baylor College of Medicine

    lead OTHER

Principal Investigators

  • Erich M. Sturgis · Baylor College of Medicine

Eligibility

Min Age
50 Years
Max Age
64 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-28
Primary Completion
2027-03-28
Completion
2027-03-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02897427 on ClinicalTrials.gov